Author:
Palmisano L,Giuliano M,Galluzzo CM,Amici R,Andreotti M,Weimer LE,Pirillo MF,Fragola V,Bucciardini R,Vella S
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Reference15 articles.
1. 1 El-Sadr WM , Lundgren JD , Neaton JD et al. Strategies for management of antiretroviral therapy (SMART) study group. CD4 count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355: 2283-2296.
2. 2 Panel on antiretroviral guidelines for adults and adolescents. Guidelines for use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 29, 2008; 1-128. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (Accessed August 30, 2008)
3. 3 Arnedo-Valero M , Garcia F , Gil C et al. Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection. Clin Infect Dis 2005; 41: 883-890.
4. 4 Ruiz L , Paredes R , Gomez G et al. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients. AIDS 2007; 21: 169-178.
5. 5 Marchou B , Tangre P , Charreau I et al. Intermittent antiretroviral therapy in patients with controlled HIV infection. AIDS 2007; 21: 457-466.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献